Area Health Institutions Attempt Translational Medicine Center
Aimed at boosting economic development and funding research, supporters call it a game-changer for Kansas City, a way to bolster the area's claim as a hub of life science research. Opponents haven't galvanized, at least in a visible way. But lots of questions are being raised.
In the second segment of Monday's Up to Date, Steve Kraske welcomes Dr. Lawrence Dreyfus, vice chancellor for research & economic development at UMKC, and David Westbrook, Senior Vice President, Strategy and Innovation, Children’s Mercy Hospital to talk about translational medicine and what they hope to spend $40 million on each year.